The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

The Decentralized Clinical Trial Operating System.

Enable universal participation in clinical trials for patients and providers, anywhere.

Making Patient and Provider
Access Possible

Orchestrate Your DCT with a Unified, Seamless Technology Platform

OS Configurations to Enable Any Study.

From a Fully Decentralized Clinical Trial, a Science 37 Metasite-enabled study (virtual-study arm), to our Technology + (hybrid) model, our Operating System can be configured to enable any study, in any indication.

Fully Decentralized

Enroll faster, retain patients longer and reach a more diverse and representative patient population with Science 37 orchestrating your study from protocol design to database lock. In a fully decentralized clinical trial model, access Science 37 telemedicine investigators as a sole study site.

Science 37 Metasite

Extend study access to a more representative, hard-to-reach patient population, or enable study continuity by adding a Science 37 Metasite to your existing site strategy. Reach more patients and bring research opportunites without infrastucture costs to their physicians - extending the investigator network and increasing patient retention.

Technology +

With the industry-leading technology platform, easily configure a solution to confidently collect quality data from eSources (eCOA/ePRO) to real-world evidence (RWE) and wearable devices while activating any element of the Science 37 DCT OS.

Configurable to Meet Your Needs.

With more DCT experience than any other company, and extensive technical, medical and operational expertise, we can work with you to consult, operationalize and deploy our DCT OS to meet the needs of your study.

Technology Configurations

From eConsent and eSource (eCOA/ePRO) data collection to telemedicine and third-party integration, our industry-leading technology can be configured to fit any study requirement with our unified, streamlined Operating System.

Network Configurations

Activate our patient engagement network or tap into our in-depth telemedicine investigator expertise to configure our DCT OS networks and enable any element of a decentralized clinical trial.

Study Configurations

Support any phase of a study, including pivotal trials or RWE (long-term, follow-up) studies for any number of indications such as oncology, CNS, endocrinology, pediatrics, infectious and rare disease with our DCT OS.

Trial Delivery, the Science 37 Way.

As the pioneer of decentralized clinical trials, we have operationalized more interventional DCTs than any other provider across a myriad of indications with proven delivery - ensuring success along the entire trial continuum with the Science 37 DCT OS coupled with the Science 37 Way for Operational Excellence.